Answers are grounded in this paper and cite their sources.
Background Lower-limb injuries are common in athletes. Neuromuscular training (NMT) is widely promoted, but the comparative effectiveness of different modalities and the optimal dose remain uncertain. Methods We conducted a PRISMA-compliant, PROSPERO-registered systematic review and meta-analysis of randomised controlled trials. PubMed, Web of Science, Scopus, Cochrane Library and Embase were searched to 1 August 2025. Eligible trials compared NMT with a control in athletes and reported lower-limb injury outcomes. Random-effects models pooled risk ratios (RRs) with 95% confidence intervals (CIs). Two reviewers screened, extracted and assessed risk of bias. Prespecified subgroups examined modality and dose (frequency, session duration, intervention length), age, sex and sport. Certainty was rated with GRADE. Results Twenty-seven RCTs (27,663 participants) were included. NMT was associated with reduced lower-limb injury risk (RR = 0.72, 95% CI 0.64–0.82), although trim-and-fill adjustment attenuated the estimate. Structured (RR = 0.68, 95% CI 0.56–0.82) and multidimensional programmes (RR = 0.76, 95% CI 0.61–0.93) showed favourable pooled estimates, with no statistically significant between-modality difference. Favourable pooled estimates were also observed in adolescents (RR = 0.67, 95% CI 0.55–0.81) and young adults (RR = 0.70, 95% CI 0.50–0.99), and in football (RR = 0.71) and basketball (RR = 0.66); however, the between-age difference did not remain statistically significant after Benjamini–Hochberg false discovery rate correction, and no statistically significant differences were detected between sport subgroups. Low-certainty, study-level subgroup analyses yielded favourable pooled estimates for programmes delivered 2–3 times per week, for 16–25 min per session, and over intervention periods of 1.5–12 months; however, these associations did not establish a causal or optimal dose. Certainty was very low overall and low to very low across dosage comparisons. Conclusions NMT may reduce lower-limb injury risk, but the magnitude of benefit remains very uncertain. Structured and multidimensional programmes, together with programmes delivered at moderate frequency and duration, showed favourable pooled estimates in exploratory subgroup analyses; however, the dose-related findings represent study-level associations and should not be interpreted as evidence of a causal or optimal dose. These findings may inform the design of routine training programmes, while future high-quality RCTs should address adherence, long-term sustainability, and dose–response interactions across sports and populations.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: